Literature DB >> 19337280

Therapy: methotrexate guidelines: compromise to reach consensus.

Joel M Kremer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19337280     DOI： 10.1038/nrrheum.2009.41

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  7 in total

Review 1.  Methotrexate pharmacogenetics: the first step toward individualized therapy in rheumatoid arthritis.

Authors:  Prabha Ranganathan; Howard L McLeod
Journal:  Arthritis Rheum       Date:  2006-05

2.  American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

Authors:  Kenneth G Saag; Gim Gee Teng; Nivedita M Patkar; Jeremy Anuntiyo; Catherine Finney; Jeffrey R Curtis; Harold E Paulus; Amy Mudano; Maria Pisu; Mary Elkins-Melton; Ryan Outman; Jeroan J Allison; Maria Suarez Almazor; S Louis Bridges; W Winn Chatham; Marc Hochberg; Catherine MacLean; Ted Mikuls; Larry W Moreland; James O'Dell; Anthony M Turkiewicz; Daniel E Furst
Journal:  Arthritis Rheum       Date:  2008-06-15

3.  Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis.

Authors:  R A Hamilton; J M Kremer
Journal:  Br J Rheumatol       Date:  1997-01

4.  Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.

Authors:  J Braun; P Kästner; P Flaxenberg; J Währisch; P Hanke; W Demary; U von Hinüber; K Rockwitz; W Heitz; U Pichlmeier; C Guimbal-Schmolck; A Brandt
Journal:  Arthritis Rheum       Date:  2008-01

5.  Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology.

Authors:  J M Kremer; G S Alarcón; R W Lightfoot; R F Willkens; D E Furst; H J Williams; P B Dent; M E Weinblatt
Journal:  Arthritis Rheum       Date:  1994-03

6.  Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis.

Authors:  Judith M Dalrymple; Lisa K Stamp; John L O'Donnell; Peter T Chapman; Mei Zhang; Murray L Barclay
Journal:  Arthritis Rheum       Date:  2008-11

7.  Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.

Authors:  K Visser; W Katchamart; E Loza; J A Martinez-Lopez; C Salliot; J Trudeau; C Bombardier; L Carmona; D van der Heijde; J W J Bijlsma; D T Boumpas; H Canhao; C J Edwards; V Hamuryudan; T K Kvien; B F Leeb; E M Martín-Mola; H Mielants; U Müller-Ladner; G Murphy; M Østergaard; I A Pereira; C Ramos-Remus; G Valentini; J Zochling; M Dougados
Journal:  Ann Rheum Dis       Date:  2008-11-25       Impact factor: 19.103
  7 in total
  1 in total

1.  Rare incidence of methotrexate-specific lesions in liver biopsy of patients with arthritis and elevated liver enzymes.

Authors:  Emilie Quintin; Jean-Yves Scoazec; Hubert Marotte; Pierre Miossec
Journal:  Arthritis Res Ther       Date:  2010-07-16       Impact factor: 5.156
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.